D
David A. Cooper
Researcher at Pfizer
Publications - 965
Citations - 81765
David A. Cooper is an academic researcher from Pfizer. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 117, co-authored 903 publications receiving 69249 citations. Previous affiliations of David A. Cooper include Boston Children's Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy.
Gwamaka Eliudi Mwasakifwa,Cecilia L. Moore,Dianne Carey,Janaki Amin,Janaki Amin,Paul Penteado,Marcelo H. Losso,Poh Lian Lim,Lerato Mohapi,Jean-Michel Molina,Brian Gazzard,David A. Cooper,Mark A. Boyd,Mark A. Boyd +13 more
TL;DR: In low and middle-income countries implementing a public health approach to antiretroviral therapy treatment, an untimed plasma drug concentration may provide a practical method for early identification of patients with inadequate medication adherence and facilitate timely corrective interventions to prevent virological failure.
Journal ArticleDOI
Towards a universal second-line fixed-dose combination ART
Journal ArticleDOI
The acquired immunodeficiency syndrome and tuberculosis.
TL;DR: The Great Australian Salt Search is a search for answers to the mystery of why salt levels in Australia are so low.
Journal ArticleDOI
The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database
Awachana Jiamsakul,Stephen J. Kerr,Ezhilarasi Chandrasekaran,Aizobelle Huelgas,Sineenart Taecharoenkul,Sirinya Teeraananchai,Gang Wan,Penh Sun Ly,Sasisopin Kiertiburanakul,Matthew Law,P.S. Ly,Vohith Khol,F.J. Zhang,H.X. Zhao,N. Han,M.P. Lee,P.C.K. Li,W. Lam,Y.T. Chan,N. Kumarasamy,Suneeta Saghayam,C. Ezhilarasi,S Pujari,Kedar Joshi,S. Gaikwad,A. Chitalikar,Tuti Parwati Merati,Dewa Nyoman Wirawan,F. Yuliana,Evy Yunihastuti,D. Imran,Alvina Widhani,Shinichi Oka,Junko Tanuma,T. Nishijima,J.Y. Choi,S. Na,J.M. Kim,B.L.H. Sim,Y.M. Gani,R. David,Adeeba Kamarulzaman,Sharifah Faridah Syed Omar,Sasheela Ponnampalavanar,Iskandar Azwa,Mahiran Mustafa,N. Nordin,R. Ditangco,Elenore Judy B. Uy,R. Bantique,W.W. Wong,W.W. Ku,P.C. Wu,O.T. Ng,P.L. Lim,L.S. Lee,R. Martinez-Vega,Praphan Phanuphak,K Ruxrungtham,Anchalee Avihingsanon,P. Chusut,Sasisopin Kiertiburanakul,Somnuek Sungkanuparph,L. Chumla,N. Sanmeema,Romanee Chaiwarith,Thira Sirisanthana,Wilai Kotarathititum,Jutarat Praparattanapan,Pacharee Kantipong,P. Kambua,Winai Ratanasuwan,R. Sriondee,K.V. Nguyen,V.H. Bui,D.T.H. Nguyen,D.T. Nguyen,T.T. Pham,D.D. Cuong,H.L. Ha,A.H. Sohn,Nicolas Durier,B. Petersen,David A. Cooper,M.G. Law,A. Jiamsakul,David C Boettiger +86 more
TL;DR: Investigation of "Simpson's paradox" in an Asian HIV cohort and the effects of site-level adjustment through various Cox regression models suggests greater emphasis should be made to include site in survival models when possible.
Journal ArticleDOI
Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV
Juergen K. Rockstroh,Joseph J. Eron,David A. Cooper,Roy T. Steigbigel,Nguyen,Xia Xu,Hong Wan,Anthony Rodgers,Michael D. Miller,Randi Y. Leavitt,Peter Sklar,Hedy Teppler +11 more
TL;DR: 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK.